Literature DB >> 669816

Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection.

S B Greenberg, B S Criswell, H R Six, R B Couch.   

Abstract

Peripheral blood leukocytes obtained from volunteers at various times following influenza vaccine or live influenza virus infection were assayed for cytotoxicity against influenza virus-infected cells. Cytotoxicity was highest on days 3 and 7 following vaccination with commercial A/Port Chalmers/1/73 inactivated influenza virus vaccine. Maximal cytotoxicity was found 9 days after infection induced by intranasal inoculation of a strain of A/Scotland/840/74 influenza virus. Individuals naturally infected with A/Victoria/3/75 were also found to have elevated cytotoxicity approximately 1 week after onset of illness. Cytotoxicity levels decreased toward base line approximately 30 days after the virus exposure. The effector mechanism(s) responsible for the early, transient elevation in specific immune release to influenza virus-infected cells may be different from the antibody-dependent cell cytotoxicity demonstrated in the peripheral blood leukocytes from volunteers who had a remote experience with influenza virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 669816      PMCID: PMC421906          DOI: 10.1128/iai.20.3.640-645.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Cytotoxic macrophages: a rapid nonspecific response to viral infection.

Authors:  S J Rodda; D O White
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

2.  Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method.

Authors:  S B Greenberg; B S Criswell; R B Couch
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

Review 3.  THE USE OF VOLUNTEERS IN MEDICAL VIROLOGY.

Authors:  V KNIGHT
Journal:  Prog Med Virol       Date:  1964

4.  Lymphocyte cytotoxicity to influenza virus-infected cells. II. Requirement for antibody and non-T lymphocytes.

Authors:  S B Greenberg; B S Criswell; H R Six; R B Couch
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

Review 5.  Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics.

Authors:  M Jondal; H Wigzell; F Aiuti
Journal:  Transplant Rev       Date:  1973

6.  Radioimmunoprecipitation assay for quantitation of serum antibody to the hemagglutinin of type A influenza virus.

Authors:  H R Six; J A Kasel
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.

Authors:  L H Perrin; R M Zinkernagel; M B Oldstone
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

8.  Cell-mediated immune responses in humans after induced infection with influenza A virus.

Authors:  R Dolin; D D Richman; B R Murphy; A S Fauci
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

9.  Immune response of the human respiratory tract. II. Cell-mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses.

Authors:  P F Jurgensen; G N Olsen; J E Johnson; E W Swenson; E M Ayoub; C S Henney; R H Waldman
Journal:  J Infect Dis       Date:  1973-12       Impact factor: 5.226

10.  Cell-mediated immune response to influenza virus infections in mice.

Authors:  G Cambridge; J S Mackenzie; D Keast
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

View more
  16 in total

1.  Late-onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function.

Authors:  H Verder; E Dickmeiss; S Haahr; E Kappelgaard; J Leerbøy; A Møller-Larsen; H Nielsen; P Platz; C Koch
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

2.  Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza.

Authors:  Ane Marie Anderson; Marta Baranowska-Hustad; Ranveig Braathen; Gunnveig Grodeland; Bjarne Bogen
Journal:  J Immunol       Date:  2018-02-02       Impact factor: 5.422

3.  Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

Authors:  N Kirmani; R K Ginn; K K Mittal; J F Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

Review 4.  Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.

Authors:  Sinthujan Jegaskanda; Hillary A Vanderven; Adam K Wheatley; Stephen J Kent
Journal:  Hum Vaccin Immunother       Date:  2017-03-23       Impact factor: 3.452

5.  Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis.

Authors:  R L Hirsch; D E Griffin; R T Johnson
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

6.  Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.

Authors:  S B Greenberg; H R Six; S Drake; R B Couch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  Histopathological changes in the lungs of influenza-infected mice superinfected with Staphylococcus aureus.

Authors:  I D Gardner; T M Kung
Journal:  Br J Exp Pathol       Date:  1980-08

8.  Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine.

Authors:  G V Quinnan; F A Ennis; C U Tuazon; M A Wells; G M Butchko; R Armstrong; C McLaren; J F Manischewitz; S Kiley
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.

Authors:  Sinthujan Jegaskanda; Thakshila H Amarasena; Karen L Laurie; Hyon-Xhi Tan; Jeff Butler; Matthew S Parsons; Sheilajen Alcantara; Janka Petravic; Miles P Davenport; Aeron C Hurt; Patrick C Reading; Stephen J Kent
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Authors:  Hillary A Vanderven; Lu Liu; Fernanda Ana-Sosa-Batiz; Thi Ho Nguyen; Yanmin Wan; Bruce Wines; P Mark Hogarth; Danielle Tilmanis; Arnold Reynaldi; Matthew S Parsons; Aeron C Hurt; Miles P Davenport; Tom Kotsimbos; Allen C Cheng; Katherine Kedzierska; Xiaoyan Zhang; Jianqing Xu; Stephen J Kent
Journal:  JCI Insight       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.